The mission of the Einstein-Mount Sinai Diabetes Research Center (ES-DRC)—a joint project of Albert Einstein College of Medicine and Icahn School of Medicine at Mount Sinai—is to conduct basic, translational, behavioral, and clinical research into type 1 and type 2 diabetes and related metabolic conditions.

Areas of Research

Studies at ES-DRC fall into six major interrelated areas:

  • islet biology and immunology
  • signal transduction
  • central and peripheral regulation of metabolism
  • diabetic complications
  • metabolic patient-oriented research and diabetes-focused clinical trials
  • social-environmental determinants of metabolic health

Focus on Equity
ES-DRC investigations primarily focus their efforts to improve health equity among communities in the Bronx, New York City, and Westchester County that have disproportionally high rates of metabolic disorders, including groups that have been historically marginalized.

Resources and Collaborations

The ES-DRC also includes:

  • Diabetes-specific core facilities
  • The Pilot and Feasibility Study program, which fosters new diabetes-related research by faculty at Einstein, Mt. Sinai, and other participating institutions, and an enrichment program designed to initiate research programs in biomedical and behavioral diabetes-related areas
  • The Montefiore-Einstein Clinical Diabetes Center
  • The Global Diabetes Institute
  • The Mount Sinai Diabetes and Obesity Metabolism Institute
  • The Mount Sinai Clinical Diabetes Center

All told, ES-DRC comprises more than 100 independent laboratories—a scientific base that serves as resource for diabetes investigators nationwide. Our researchers collaborate with investigators at New York University, Weill Cornell Medical College, Cornell University, New York Medical College, Winthrop University Hospital, Stony Brook University, and Hunter College.

In additional to the National Institutes of Health, ES-DRC interacts with and provides collaborative research support to the New York Obesity Research Center and the Center for the Study of Diabetic Complications.